IP Library Granted Patent US 8,822,498
Granted Patent B2
US 8,822,498 · App. 12/283,621 · Granted Sep 2, 2014

Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof

Inventors: Andrew D. Jones (Needham, MA); Robert E. Zelle (Stow, MA); I. Robert Silverman (Arlington, MA)
Assignee: Concert Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,822,498
App. No.
12/283,621
Granted
Sep 2, 2014
Kind
B2
Abstract

The present invention provides a convenient and efficient process for the synthesis of d 2 -benzo[d][1,3]dioxoles.

Claims (6)

1. Deuterated paroxetine represented by the following structural formula or a pharmaceutically acceptable salt thereof:

wherein the isotopic enrichment of the benzo[d][1,3]dioxole group with deuterium is at least 99.0%.

2. Deuterated paroxetine represented by the following structural formula or a pharmaceutically acceptable salt thereof:

wherein the isotopic enrichment of the benzo[d][1,3]dioxole group with deuterium is at least 99.0%.

3. A pharmaceutical composition comprising the deuterated paroxetine of claim 1 and a pharmaceutically acceptable carrier.

4. A pharmaceutical composition comprising the deuterated paroxetine of claim 2 and a pharmaceutically acceptable carrier.

Assignments (2)
MERGER Recorded Aug 2, 2023
From: CONCERT PHARMACEUTICALS, INC.
To: SUN PHARMACEUTICAL INDUSTRIES, INC.
Reel/Frame 064465/0383 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2009
From: JONES, ANDREW D.; ZELLE, ROBERT E.; SILVERMAN, I. ROBERT
To: CONCERT PHARMACEUTICALS, INC.
Reel/Frame 022211/0022 →
Continuity (2)
Provisional Application 60993565 · Sep 13, 2007
Related Publication 20090143432A1 · Jun 4, 2009